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Juno and Izumo are structurally unrelated: Juno adopts a modified folate receptor family fold [@bib5], whereas Izumo1 is a type I transmembrane protein consisting of an extracellular region of about 300 residues and a short cytoplasmic tail [@bib2]. The biological activity of Izumo1 depends on the amino-terminal half of its ectodomain --- a region named the 'Izumo domain' because it is shared with the paralogous sperm proteins Izumo2, 3 and 4 [@bib6]; this region is followed by a glycosylated Ig-like domain [@bib2] ([Figure 1](#fig1){ref-type="fig"}A).

To investigate how Izumo1 might trigger gamete fusion, we expressed the entire ectodomain in mammalian cells and determined a crystal structure to 2.5 Å resolution ([Figure S1](#mmc1){ref-type="supplementary-material"} in [Supplemental Information](#app2){ref-type="sec"} and PDB ID [5B5K](pdb:5B5K){#intref0010}). The structure shows that the Izumo domain consists of a four-helix bundle with a flexible α-helical hook/β-sheet insertion, followed by a β-hairpin that connects the bundle to a seven-stranded Ig-like domain ([Figure 1](#fig1){ref-type="fig"}A,B). These features result in an elongated architecture stabilized by five intramolecular disulfide bonds that are conserved in the three Izumo paralogs, and are clearly discernible within the sequence of Spaca6, another sperm surface protein recently reported to be required for gamete fusion [@bib7] ([Figure S2](#mmc1){ref-type="supplementary-material"}A,B). This suggests that the similarity between Izumo1 and Spaca6 is not limited to the carboxy-terminal Ig-like domain, which can be superimposed onto the canonical V-set Ig-like domain of human CD2 (PDB ID [1HNF](pdb:1HNF){#intref0015}) --- a molecule mediating the adhesion of lymphocytes to antigen-presenting cells --- with a root mean square deviation (RMSD) of 2.1 Å over 86 residues.

The helical character of the carboxy-terminal half of the Izumo domain, which corresponds to helices α3 and α4 in our structure ([Figure 1](#fig1){ref-type="fig"}A,B), was shown to be important for the function of Izumo1 [@bib6]. The structure readily explains why mutation of leucine residues to proline interferes with this biological activity by disrupting the fold of the four-helix bundle ([Figure S2](#mmc1){ref-type="supplementary-material"}A,C). However, binding assays using peptides representing α3 and α4 suggest that this region of Izumo1 is either not involved in binding to Juno or not sufficient for this interaction ([Figure 1](#fig1){ref-type="fig"}C).

Strikingly, structural homology searches revealed a high confidence match between the four-helix bundle of Izumo1 and that of SPECT1, a secreted *Plasmodium* protein that is essential for host cell traversal by the infective sporozoite form of the parasite (Dali Z-score 6.9, RMSD 3.3 Å over 98 residues; [Figure 1](#fig1){ref-type="fig"}D). The nearly parallel/antiparallel arrangement of the SPECT1 helical bundle, which also contains a helical hook (albeit inserted at a different position than in Izumo1), has been suggested to adopt a metastable structure which favors the transition from a solvent-exposed to membrane-associated form [@bib8]. In addition, the β-hairpin of Izumo1 is structurally similar to the extensible β-ribbon of TRAP, another *Plasmodium* protein that mediates sporozoite gliding and host cell invasion [@bib4] (RMSD 1.4 Å over 19 residues; [Figure 1](#fig1){ref-type="fig"}E). The TRAP β-ribbon is thought to undergo conformational changes upon attachment to host cells and acts as an elbow-like flexible spacer between the amino-terminal α-helical von Willebrand factor A (VWA) domain of the protein (which interacts with the host cell) and its carboxy-terminal β-rich thrombospondin type I repeat (TSR) domain.

What might be the functional implications of the structural similarities to *Plasmodium* cell traversal and invasion proteins with Izumo1? Our findings suggest that the four-helix bundle of the Izumo domain and SPECT1 may orchestrate analogous fusion-related molecular recognition events at the sperm--egg and parasite--host cell interfaces. Izumo1 is not considered a fusogen per se because it cannot induce membrane fusion when heterologously expressed in commonly used cell lines [@bib1]. The presence of solvent-exposed bulk aromatic residues in the Izumo1 four-helix bundle ([Figure S2](#mmc1){ref-type="supplementary-material"}A; a feature also observed in SPECT1) and the report that some monoclonal antibodies that target the Izumo domain do not block binding of sperm to the egg but hinder gamete fusion [@bib6] are consistent with the possibility that an additional, as yet unknown, component is required to form a functional fusogenic complex [@bib9]. Whether SPECT1 is also part of a larger protein complex that could organize proteins that have membrane-disrupting functions, such as SPECT2, is currently unclear [@bib10].

Both SPECT1 and TRAP are expressed by the sporozoite stage of *Plasmodium* parasites and are similarly sequestered within specialized intracellular secretory organelles called micronemes [@bib3], [@bib4]. We do not yet know if these proteins, like Izumo1, have a specific binding partner that mediates cell-specific recognition events, or, as has been suggested for sp18 (a five-helical bundle sperm acrosomal protein from the mollusk abalone), are disrupting membrane structure by interacting directly with phospholipids. Nevertheless, it is intriguing that, similar to SPECT1 and TRAP, Izumo1 is sequestered in the acrosome and that its release is also highly regulated by localized secretion.

The structure of Izumo1 provides new mechanistic insights into a fascinating basic biological process and, also considering the protein's recent implication in human immunoinfertility, presents new opportunities in the rational design of new fertility treatments and contraceptives.
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![Experimental results and structural comparisons with *Plasmodium* invasion proteins.\
(A) Domain architecture of the extracellular region of Izumo1. The Izumo domain, which consists of a four-helix bundle (α1--α4), an insertion (ins: α2/3 hook and β0) and a β-hairpin (β1--β2) --- see panel (B) --- is boxed. A protease-sensitive carboxy-terminal region that was included in the expression construct used for this study, but is not defined in the electron density map, is indicated by a dashed line. (B) Crystal structure of mouse Izumo1 (amino acids C22--K256), shown in cartoon representation with different regions of the molecule colored as in (A). Amino/carboxyl termini and secondary structure elements are marked. Cysteine residues and the N-acetylglucosamine (NAG) residue attached to N204 are represented in ball-and-stick notation, with circled pink numbers indicating the five disulfide bonds (see also [Figure S2](#mmc1){ref-type="supplementary-material"}A). (C) Microscale thermophoresis experiments show that Juno directly binds to the Izumo1 ectodomain, but does not interact with peptides corresponding to Izumo1 helices α3 and α4 (or an equimolar mixture thereof), which span a region reported to be sufficient for binding to the egg membrane [@bib6]. Vertical error bars represent s.d. of the mean (n ≥ 3). (D) Structural alignment of the four-helix bundles of Izumo1 and *Plasmodium* SPECT1 (PDB ID [4U5A](pdb:4U5A){#intref0025}[@bib8]), in side (left) and top (right) views. Izumo1 helices are colored as in (A,B), SPECT1 is grey. By optimizing the match found by Dali, 84 residues can be superimposed with a RMSD of 3.0 Å. (E) Superposition of the β-hairpin of Izumo1 (red) and the extensible β-ribbon of *Plasmodium* protein TRAP (black; PDB ID [4HQO](pdb:4HQO){#intref0030}[@bib4]). Both elements separate amino-terminal α-helical domains from carboxy-terminal β-rich regions in the respective proteins.](gr1){#fig1}
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